Real-World Effectiveness of Palbociclib Plus Letrozole vs Letrozole Alone for Metastatic Breast Cancer With Lung or Liver Metastases: Flatiron Database Analysis

BACKGROUND: Cyclin-dependent kinase 4/6 inhibitors are a standard treatment for patients with hormone receptor−positive (HR+)/human epidermal growth factor receptor 2−negative (HER2−) metastatic breast cancer (MBC). However, real-world data on effectiveness in patients with liver or lung metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Brufsky, Adam, Liu, Xianchen, Li, Benjamin, McRoy, Lynn, Layman, Rachel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291245/
https://www.ncbi.nlm.nih.gov/pubmed/35860587
http://dx.doi.org/10.3389/fonc.2022.865292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291245/
https://www.ncbi.nlm.nih.gov/pubmed/35860587
http://dx.doi.org/10.3389/fonc.2022.865292

Ejemplares similares